Raanana, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative ...

FDA PDUFA review goal date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT)Assuming ...

Up to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...

The Food and Drug Administration (FDA) has approved neffy ® (epinephrine nasal spray) 1mg for the emergency treatment of type 1 allergic reactions, including anaphylaxis, in pediatric patients aged 4 ...

Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS ...

Shares of the company were up 5.2% in extended trading. The spray, sold under the brand name neffy, will be dosed at 1 ...

The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic ...

Tiziana is seeking FDA clearance for a Phase 2 clinical trial testing the safety and efficacy of its foralumab nasal spray in ...

Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS ...

A Mass General Brigham-led study in preclinical models suggests that a nasal spray being tested for use in preventing Alzheimer’s disease could also reduce neuroinflammation in traumatic brain ...

The FDA (Food and Drug Administration) recently approved a new product, called ReCell, designed to treat severe burns to the body all with a single spray. Confused? Let’s start from the beginning.

CINCINNATI (WKRC) - The Food and Drug Administration issued a recall for certain nasal spray that tested positive for a bacterial contaminate that could lead to "potentially life-threatening ...